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Abstract—Metabolic pathways in cells convert external food
and resources into useful cell components and energy. In many
cases the cell employs product inhibition to regulate and control
these pathways. We investigate the performance of such regula-
tion and control on certain autocatalytic pathways. Speciﬁcally,
we examine how well the pathways can maintain the desired
output concentrations in the presence of disturbances, such as
perturbations in resources, enzyme concentrations and product
demand. Using control theoretic tools, we show the effects of
the pathway size, the reversibility of the intermediate reactions
and the coupling of pathways through the consumption of inter-
mediate metabolites on performance. In addition, we establish
some necessary conditions on the existence of ﬁxed points and
their stability for such pathways.
I. INTRODUCTION
Cell metabolism converts external food and resources to
useful cell components and energy, using a series of enzymat-
ically catalyzed chemical reactions organized in metabolic
pathways. One of the ways that cells regulate (control)
these pathways is by product inhibition, a process through
which a product of the pathway binds to an enzyme causing
the enzyme to change shape and become less effective
(allosteric regulation). Some of these metabolic pathways are
autocatalytic, i.e., they contain reactions that consume one
of the pathway’s own products. Autocatalytic processes are
found at every scale in biology, ecology, and technology. The
most basic and also the most studied is glycolysis, which is at
the heart of metabolism. The glycolysis pathway, which is the
main source of anaerobic energy production, initially requires
the consumption of 2 ATP molecules (energy carriers) and
later in the pathway produces 4 ATP molecules [1]. In
addition, metabolic pathways within the cell do not act in
isolation, but are an integral part of the whole cell activity.
They are coupled with other networks through the sharing of
components and the exchange of their intermediate products.
Glycolysis, for example, provides many of the necessary in-
termediates used to produce amino acids, lipids, nucleotides,
and other organic molecules essential to the function of
the cell [1]. In this paper we investigate pathways with the
topology shown in ﬁgure 1. Speciﬁcally, these pathways are
composed of a chain of reversible reactions that convert one
metabolite to another and require the consumption of the
ﬁnal product to convert their input into the ﬁrst metabolite.
Additionally, the product of the pathway inhibits the enzyme
that catalyzes the autocatalytic reaction and the pathway
product and intermediate metabolites are consumed by other
processes in the cell.
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Fig. 1. The autocatalytic network is composed of a chain of reversible re-
actions (black arrows) that convert one metabolite (black circles) to another.
The pathway requires the consumption of the ﬁnal product (blue triangles)
to convert its input into the ﬁrst metabolite. Additionally, the product
of the pathway inhibits (dotted red line) the enzyme that catalyzes the
autocatalytic reaction and the pathway product and intermediate metabolites
are consumed by other processes in the cell (dotted blue arrows).
Nonlinear stability and region of attraction properties for
such autocatalytic pathways (with application to glycolysis
pathway) are the subject of [2], [3], focusing on the case
in which the intermediate reactions are not reversible and
there is no intermediate metabolite consumption. For general
biochemical networks, stability and the existence of steady
states have been the subject of study for many decades. Re-
sults regarding the number of steady states and convergence
properties around steady states for rather general networks
with mass-action kinetics are established in [4], [5], [6]. Lo-
cal and global convergence properties have been established
for many network topologies such as monotone dynamical
systems [7], [8] and cyclic interconnection networks [9],
[10], [11], [12].
Here, we are primarily interested on the performance
of autocatalytic metabolic pathways near their biological
operating point. In particular, we study how the pathway can
best maintain the desired output concentration in the presence
of disturbances such as perturbations in resource availability,
product demand and enzyme concentrations using feedback
inhibition. Using tools from linear systems theory, our previ-
ous work on a simple two-state pathway (ﬁgure 2a) showed
that autocatalysis can aggravate controller performance [13].
We have shown that this reduced model captures the essence
of glycolysis pathway and glycolytic oscillations, but it
is sensitive to parameter perturbations and exhibits a very
rich dynamic behavior. Perturbations in the parameters can
make the system undergo a variety of bifurcations, such
as saddle-node, Hopf and homoclinic bifurcations [2], [14].
This can cause the system to oscillate (limit cycles) or
even crash, implying that none of the theorems or existing
theory that rule out such behavior are applicable. Since
this level of parameter sensitivity of the dynamics is not
immediately obvious from the structure of the reduced model
or the underlying biology, it is important to explore more
realistic pathway models and examine how perturbations in
the structure of the chemical reactions in the pathway model
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Fig. 2. Performance in the different network topologies (reversibility of
intermediate reactions (b), large pathways (c) and intermediate metabolite
consumption (d)), is compared to that of the simplest two-state pathway (a).
effect dynamics and performance. In this paper, we inves-
tigate how the size of the pathway, the reversibility of the
intermediate reactions and the coupling of pathways through
the consumption of intermediate metabolites effect their
performance (ﬁgure 2). In the case when there is coupling
to other pathways via intermediate metabolite consumption,
we establish some necessary conditions on the existence of
ﬁxed points.
The rest of the paper is organized as follows: We introduce
the pathway model in the next section, followed by a
discussion of control and performance in section II-A. Next
we consider the different topologies separately, by looking
at large pathways in section III, pathways with reversible
reactions in section IV and pathways with intermediate
metabolite consumption in section V. The more general
pathways are discussed in section VI.
II. MODEL DESCRIPTION
Consider the autocatalytic metabolic pathway with multi-
ple intermediate metabolite reactions (ﬁgure 1)
u+ ay ⇀f x1
x1 g1l2 x2 
g2
l3
· · · gn−1ln xn
d1 d2 dn
ϕ ϕ ϕ
xn gnly (a+ b) y ⇀
gy ϕ
Here, u is some precursor and source of energy for the
pathway with no dynamics associated, y denotes the product
of the pathway, xi are intermediate metabolites, ϕ is a null
state, a is the number of y molecules that are invested in the
pathway, and a+ b is the number of y molecules produced.
A ⇀f B denotes a chemical reaction that converts chemical
species A to species B at rate f and A  B denotes a
reversible reaction (i.e., both the reaction that converts A
to B and the one that converts B to A are present). The
P 
hˆ
-

Fig. 3. Block diagram of system (2).
corresponding ordinary differential equations are
x˙1 = f(y) + l2(x2)− g1(x1)− d1(x1)
x˙2 = g1(x1) + l3(x3)− g2(x2)− l2(x2)− d2(x2)
...
x˙n−1 = gn−2(xn−2) + ln(xn)− gn−1(xn−1)
−ln−1(xn−1)− dn(xn−1)
x˙n = gn−1(xn−1) + ly(y)− gn(xn)
−ln(xn)− dn(xn)
y˙ = (a+ b)gn(xn)− af(y)− (a+ b)ly(y)− gy(y),
(1)
for xi ≥ 0, y ≥ 0. Here, g1, . . . , gn, l2, . . . , ln, ly, d1, . . . , dn,
and gy are continuous, monotone, increasing functions that
vanish at 0. These assumptions are consistent with large
classes of chemical kinetics models such as mass-action
and Michaelis-Menten. The rate f(y) of the autocatalytic
reaction captures the negative feedback of the output (y) via
the inhibition of the catalyzing enzyme of the ﬁrst reaction.
We choose f(y) = V y
q
1+γyh
that is consistent with biological
intuition and experimental data (in the case of the glycolysis
pathway [15], [16]). In this parameterization V > 0 depends
on the concentration of the input (u), q > 0 captures the
strength of autocatalysis and γ > 0 and h > 0 capture
the strength of inhibition (negative feedback). Note that f
is not monotone and captures the coupling between the
autocatalysis and inhibition. For the rest of the paper, we
take a = b = 1 and note that the generalization of the results
for a > 0 and b > 0 is straightforward.
A. Feedback Mechanism, Sensitivity Function, Zeros
If a nonzero ﬁxed point (x¯, y¯)  (0, 0) of (1) exists, then
without loss of generality we set y¯ = 1 (and assume so for
the rest of the paper). Deﬁne hˆ := γγ+1h, and
V0 := f(1) =
V
1+γ ri :=
∂
∂xi
li(xi)|x¯
ki :=
∂
∂xi
gi(xi)|x¯ ηi := ∂∂xi di(xi)|x¯
ky :=
∂
∂y gy(yi)|1 ry := ∂∂y ly(y)|1.
The dynamics of (1) near the ﬁxed point are given by the
following linear system
[
x˙
y˙
]
=
(
J0 − hˆBC
)[
x
y
]
(2)
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for x ∈ Rn, y ∈ R and where B := V0 [1, 0, . . . , 0,−1]T ,
C := [0, 0, . . . , 0, 1] , J0 is⎡
⎢⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
−m1 r2 0 · · · 0 0 qV0
k1 −m2 r3 0 0 0
0 k2 −m3 . . . 0 0 0
. . . . . .
...
0 0 0 −mn−1 rn 0
0 0 0 kn−1 −mn ry
0 0 0 · · · 0 2kn −δy − qV0
⎤
⎥⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
and for all i, mi := ki+ ri+ ηi, r1 := 0 and δy = ky +2ry .
Notice that equation (2) can be viewed as the closed-loop
dynamics of
ξ˙ = J0ξ +Bν
ζ = Cξ.
(3)
using a proportional (negative) feedback controller of gain
hˆ (i.e., ν = −hˆζ). Biologically, the gain hˆ captures the
strength of the inhibition of the autocatalytic reaction by
the pathway product (in the case of glycolysis, it captures
the strength of inhibition of the catalyzing enzyme PFK by
ATP [2]). Figure 3 shows the feedback structure of system
(3), where P (s) := C(sI − J0)−1B. In this paper, we
explore the performance of the controller on the different
network topologies shown in ﬁgure 2 by investigation of
the sensitivity function S, given by S(s) = 1
1+hˆP (s)
. S
captures the ability of the system to reject many relevant
disturbances, such as perturbations δ in the pathway product
consumption rate (i.e., perturbations of the RHS of equation
(2) by [0, . . . , 0, 1]T δ) or in the consumption rate of other
metabolites. In the topologies we investigate, the plants P
have right half-plane (RHP) zeros which introduce theoretical
limits on performance captured by a special form of the
Bode’s integral formula [13],
1
π
∫ ∞
0
ln |S(jω)| 2z
z2 + ω2
dω = M ≥ 0 (4)
where z is a RHP zero and M = ln | z+pz−p¯ | > 0 if the open-
loop plant has a RHP pole p, and M = 0 otherwise. Notice
that these limits are exacerbated by smaller magnitude RHP
zeros, since it severely penalizes performance in frequencies
below z. Reference [13] characterizes the limits and the
tradeoffs involved for a special form of the two-state model
shown in ﬁgure 2a. In particular it shows that performance
improves as the concentration of the intermediate enzyme
increases (higher intermediate reaction rate). Here, using the
two-state model in ﬁgure 2a as a basis for comparison,
we investigate how limits on performance change as this
two-state model is extended to include multiple intermediate
states (ﬁgure 2c), reversibility of the intermediate reactions
(ﬁgure 2b) and consumption of intermediate metabolites by
other pathways (ﬁgure 2d).
Comparison of performance in these different topologies
can be tricky, since these topologies imply fundamental
changes in the “plant” and the number and locations of the
ﬁxed points of the (nonlinear) closed loop system (1). The
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Fig. 4. (left) The magnitude of the RHP zero decreases as pathway size
increases. (right) The weight in the Bode integral gets tighter around 0
for longer pathways. This means the price paid for performance at small
frequencies increases substantially as the number of intermediate reactions
increases.
assumption that the (operating) equilibrium concentration
of the pathway output y is ﬁxed and normalized to 1 for
all topologies makes such comparisons appropriate, since it
directly addresses the question of which topology is easier
to control, i.e., in which pathway topology the controller can
best maintain the desired concentration of the output y of the
pathway in the presence of disturbances.
III. LONGER PATHWAYS
In this section we investigate the topology of ﬁgure 2c,
i.e., a pathway of size n+1 with no reversible reactions and
no consumption of any of the intermediate metabolites (in
equation (1), ly(y) = 0, li(xi) = 0, di(xi) = 0, ∀i). Then
P (s) = C (sI − J0)−1B
= V0
∏n
i=1(ki+s)−2
∏n
i=1 ki
(ky+qV0+s)
∏n
i=1(ki+s)−2qV0
∏n
i=1 ki
.
(5)
The coefﬁcients of the numerator of P (s), given by
n1(s) =
∏n
i=1 (ki + s)− 2
∏n
i=1 ki
= sn + (k1 + · · ·+ kn) sn−1 + · · ·+ (−
∏n
i=1 ki) ,
do not have the same sign. This implies that the polynomial
n1(s) is not Hurwitz stable and therefore P (s) has at least
one RHP zero and equation (4) holds for the n-D pathway.
Let us look at the case where ki = k, for all i. Deﬁne
hˆd(n) := q+
ky
V0
θ(n)
2+θ(n) , θ(n) := (sec(π/(n+ 1)))
n+1, then
the system is stable for gains q − 1 < hˆ < hˆd(n) [3], [11].
This implies that, in general, as the pathway size increases,
the upper bound on stable feedback gains hˆ decreases. The
zeros of P (s) are given by s = k
(∣∣∣2 1n ∣∣∣ ej 2πin − 1) , ∀i.
As expected, there is at least one zero in the RHP. The
magnitude of this RHP zero decreases as the size of the
pathway (n) increases (ﬁgure 4 left).
This fact, coupled with the conservation law given by (4),
implies that as the number of intermediate reactions grows
the price paid for performance at small frequencies increases
substantially (ﬁgure 4 right). So the increase in the interme-
diate metabolite reactions has two main consequences.
• The price for good performance at low frequencies
increases as the magnitude of the RHP zero gets smaller.
• The upper bound on the feedback gains gets smaller, so
the range of stable gains gets smaller.
For example look at the DC gain (steady state error) of a
n-D system with q = 2, ky = V0 = 1. From (5) we get
P (0) = 1 and the DC gain S(0) = 1
1+hˆ
. It is clear that
the DC gain improves as the gain increases, however the
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Fig. 5. The performance of two-state, three-state and four-state systems
is compared. The intermediate reaction rates are k1 = k2 = k3 = 1 and
q = 2, ky = V0 = 1. (top-left) Plot of log |S| for the same feedback
hˆ = 3.8, shows that the higher dimension systems pay a higher price at
higher frequencies for similar performance at low frequencies (top-right)
Closed-loop system step response shows that the same gain hˆ = 3.8 yields
the same steady state error for all 3 systems. However higher dimensional
systems have poorer transient response. (bottom-left) Lower dimensional
systems have access to higher gains, which means that they can get better
performance at low frequencies. The plot of log |S| for hˆ = 5.5, 4, 3.8
for two-state, three-state and four-state systems respectively, illustrates the
difference in performance at low frequencies, and the price paid at higher
frequencies (comparable for all 3 systems). (bottom-right) Closed-loop
system step response shows that access to higher gains for the low dimension
systems (hˆ2D = 5.5, hˆ3D = 4, hˆ4D = 3.8) achieves smaller steady state
error and better transient response as well.
maximum hˆ that still stabilizes the system gets smaller as n
increases. Therefore lower dimensional systems can achieve
better DC gain (steady state error). Figure 5 illustrates the
consequences of increased pathway size on performance by
looking at log |S| and the step response for comparable two-
state, three-state and four-state systems.
In general, long pathways in the cell can be biochemically
unavoidable or even necessary (such as the intermediate
metabolites are crucial to other processes in the cell). The
cell uses means such as employing metabolite channeling
[17] instead of free diffusion, to counteract the adverse effect
of large pathway size.
IV. REVERSIBLE REACTIONS
We investigate the topology of ﬁgure 2b, i.e., a pathway
of size 2 with one reversible intermediate reaction, but no
consumption of the intermediate metabolite (in equation (1)
n = 1, d1(x1) = 0).
The system is stable for gains q − 1V0 ky < hˆ < q +
1
V0
(k1 + ky + 2ry) and so the presence of the reversible
reactions increases the range of stable gains hˆ. This suggests
that the reversible reactions make the pathway easier to
control. There is still a RHP zero at s = k1 since P (s) =
−V0 s−k1pJ0 (s) , where pJ0 is the characteristic polynomial of
J0. This implies that equation (4) holds for this system.
However, because the range of the stable gains is larger
for higher reversible reaction (RR) rates, the same feedback
gain is more “robust”. This suggests that systems with higher
RR rates have better performance (i.e., smaller peak in the
log |S|, and smaller oscillations in the step response, (ﬁgure
6 top-left, top-right). It also means that higher gains can
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Fig. 6. The performance of three two-state models with k1 = 1, q =
2, ky = 1, V0 = 1 and ry = 2, 1, 0 is compared. (top) Using the same
feedback gain hˆ = 3.5 , the systems with higher reversible reaction (RR)
rates have better performance (i.e., smaller peak in log |S| (top-left), and
smaller oscillations in the step response (top-right)). (bottom) Models with
higher reversible reaction rates allow for higher stabilizing gains. Using hˆ =
7.5, 5.5, 3.5 respectively, we obtain better performance at low frequencies
(bottom-left) and better steady state error (bottom-right) for the systems
with higher RR rates.
be used for systems with high RR rates to obtain better
performance at low frequencies and better steady state error
without a meaningful increase in performance losses at high
frequencies and qualitatively similar oscillations in the step
response, as shown in ﬁgure 6 bottom-left and bottom-right.
The improvement in performance by having reversible
reactions is to be expected, since the reversible reactions act
as local feedback loops. For example the pathway studied in
this section, is (locally) equivalent to a two state pathway
with no reversible reaction, but where the product y controls
both the autocatalytic and the intermediate reaction.
V. CONSUMPTION OF INTERMEDIATES
For the topology of ﬁgure 2d, i.e., a pathway of size
2 with a single intermediate metabolite and no reversible
intermediate reaction, but with consumption of the inter-
mediate metabolite from external sources (in equation (1)
n = 1, ly(y) = 0), a ﬁxed point (x0, y0)  (0, 0) exists only
if d1(x0) < g1(x0). I.e., there cannot be more intermediate
metabolite consumption by other pathways than the current
pathway. If the desired operating ﬁxed point (x0, 1) exists,
then it is stable for
q − 1
V0
ky
k1 + η1
k1 − η1 < hˆ < q +
1
V0
(k1 + ky + η1)
and it can be shown that it is open-loop (hˆ = 0) stable when
η1 is close enough to k1. Notice that η1 cannot be larger
than k1, since for δ := η1 − k1 > 0 and δ < ky η1+k1η1+k1+ky ,
the system is not stabilizable.
Under the above conditions, the consumption of the in-
termediate increases the range of stable gains hˆ. Similar
to the RR case, this suggests that the consumption of the
intermediate metabolite might make the pathway easier to
control. However, the plant has a RHP zero at s = k1 − η1
since P (s) = −V0 s−k1+η1pA(s) . This implies that as η1 increases
the magnitude of the RHP zero gets smaller, thus imposing
harder constraints on performance. There appears to be
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is compared. Using the same feedback
gain hˆ = 3 , the systems with less consumption of intermediates have better
performance, which corresponds to a smaller peak in log |S| plot, and less
oscillations in the step response.
another tradeoff, and it is not immediately clear whether or
not the consumption of intermediates helps the performance
of the system. Deﬁne m(x) := gx(x)+dx(x) and α(x) such
that d(x) = α(x)m(x). This results in a system of the form;
x˙ = V y
q
1+γyh
−m(x)
y˙ = (2− α(x))m(x)− V yq
1+γyh
− gy(y).
These equations show that consumption of intermediates has
the same effect as reducing the net product of the pathway.
For example, if gx(x) = kx and dx(x) = βkx, then
α = ββ−1 and this pathway is equivalent to a pathway with
gx(x) = (1 + β)kx that produces (2 − α) molecules of y
for each molecule y invested. As Figure 7 shows, larger β
leads to worse tradeoffs on achievable performance and more
oscillations for the same steady state error.
VI. GENERAL PATHWAYS
We now consider the general autocatalytic metabolic path-
way given by equation (1) (ﬁgure 1).
A. Existence of the Fixed Point
Let us ﬁrst consider ly = 0, li = 0, ∀i, i.e., no reversible
intermediate reactions. Assume that the ﬁxed point (x¯, y¯) 
(0, 0) exists, then(
2
n∏
i=1
gi(x¯i)
gi(x¯i) + di(x¯i)
− 1
)
f(y¯) = gy(y¯).
This implies that the ﬁxed point (x¯, y¯)  (0, 0) exists only
if
2
n∏
i=1
pi(x¯i)− 1 > 0 (6)
where pi(x¯i) :=
gi(x¯i)
gi(x¯i)+di(x¯i)
. We can think of pi(x¯i) as
the “rate” that a molecule xi will continue to the next step
of the pathway (i.e., will be converted into xi+1), and 1 −
pi(x¯i) =
di(x¯i)
gi(x¯i)+di(x¯i)
the rate that it will be used by another
pathway. Then the rate that a molecule x1 (produced by the
ﬁrst reaction through the investment of 1 molecule of y)
will ultimately be converted into 2 molecules of y and not
be used by other pathways is given by
∏n
i=1 pi(x¯i). So for
each investment of 1 molecule of y at the start, the pathway
returns Ep [y] = 2 (
∏n
i=1 pi(x¯i)) molecules of y at the end.
Condition (6) states that for a ﬁxed point to exist, the
return Ep [y] should exceed the value of the investment, i.e.,
each molecule y invested must produce at least one molecule
of y (Ep [y] > 1). So in order for the pathway to have
a stable operating ﬁxed point it must not allow excessive
consumption of the intermediate metabolites. For example,
let di(xi) = αigi(xi), then condition (6) becomes
n∏
i=1
1
1 + αi
>
1
2
.
If αi = α for all i = 1, . . . , n then α <
n
√
2 − 1. So for a
pathway of size 10, α has to be less than 0.072, i.e., only
a small percentage of the intermediate metabolites can be
consumed at each step.
In the general case, where the intermediate reactions
are reversible, we can get a similar condition to (6) by
considering the “net ﬂow” gi(xi) − li+1(xi+1) through the
pathway (i.e., deﬁne pi :=
gi−li+1
gi−li+1+di , ∀i, with ln+1 = ly).
B. Stability of the Fixed Point
For the cases when a nonzero ﬁxed point (x¯, 1)  (0, 0)
of (1) exists, we establish bounds on gains hˆ that guarantee
stability of the pathway for arbitrary size (n) and arbitrary
values of intermediate reaction rates (gi,di,li, ly)
Proposition 1: (a) Let hˆr := q + 13
ky
V0
and hˆs := q − kyV0 .
If hˆs < hˆ ≤ hˆr, then (2) is stable for arbitrary size (n) and
arbitrary values of (ki,ηi,ri, ry) at equilibrium.
(b) The bounds above are tight, i.e. for any gain hˆ /∈
(hˆs, hˆr], there exists an unstable pathway.
Proof: (a) Proved directly by showing diagonal domi-
nance of
Q :=
[
In 0
0 2
]−1 (
J0 − hˆBC
)[
In 0
0 2
]
.
(b) For hˆ ≤ hˆs, let n = 1, ry = 0, d1 = 0 in (2). For
these parameter values, the resulting two-state system (2) is
unstable.
We now show we can construct an unstable system for any
hˆ = hˆr + ,  > 0.
In equation (2), let ry = 0, and for all i, ri = 0, ηi = 0,
ki =
2
3ky − V0 = k > 0. The characteristic polynomial
pJ(s) of J0 − hˆBC is given by
pJ(s) =
(
s+ ky + V0
(
q − hˆ
))∏n
i=1 (s+ ki)
−2V0
(
q − hˆ
)∏n
i=1 ki
= (s+ k)
n+1
+ kn (k + 3V0) .
The eigenvalues λi are then given by λ = k (ω − 1) such that
ωn+1 = (−1− 1)1/(n+1), where 1 := 3V0k . The real part
of the eigenvalue λ0, is given by (λ0) = k(−1+γ(n+1)),
where
γ(n) := (1 + 1)
1/n cos πn = 1 +
1
n log(1 + 1) +O(
1
n2 ).
This implies that for n large enough, the system (2) is
unstable since γ(n) > 1 and therefore (λ0) > 0.
VII. CONCLUSIONS
Output feedback regulation of the pathway shown in ﬁgure
1, can counteract the destabilizing effects of the positive
feedback generated by autocatalysis, thus guaranteeing the
local stability of the operating ﬁxed point. However the
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Fig. 8. The effect of increases in enzyme concentrations (EC), pathway size
(PS), intermediate metabolite consumptions (IC), and reversible reactions
(RR) on the performance and range of stable feedback gains.
structure of autocatalysis limits the range of stable feedback
gains hˆ, because the product of the pathway both controls
and is consumed by the ﬁrst reaction. An upper bound hˆd(n)
on the feedback gains hˆ suggests that the range of available
stable gains gets smaller as the pathway size increases. On
the other hand, consumption of intermediate metabolites and
the presence of reversible reactions increases the range of
stable gains. For the general model described by (1) there
exist lower and upper bounds, respectively hˆs, hˆr, on the
feedback gain hˆ that guarantee stability for arbitrary pathway
size as well as arbitrary values of both the (reversible)
reaction rates and the intermediate consumption rates. These
bounds are tight in the sense that for gains that lie outside the
ranges established by these bounds, we can construct speciﬁc
unstable pathways.
The existence of a RHP zero z is at the core of many of
the limitations imposed on performance for these pathways,
captured by a special form of the Bode Sensitivity Integral.
These limitations are aggravated by smaller magnitude RHP
zeros. As shown in [13], high concentration of catalyzing
enzymes leads to an increase in the rates of the interme-
diate reactions (ki), which makes the pathway more stable
(i.e., there is a larger range of stable gains available) and
increases the magnitude of z (i.e., “softens” the hard limits
on performance).
Increased pathway size has the opposite effect of increas-
ing the enzyme concentrations on pathway performance. An
increase in the size of the chain of enzymatically catalyzed
intermediate reactions in the autocatalytic pathways causes
two adverse effects on performance: tradeoffs on perfor-
mance limits are exacerbated (as z becomes smaller) and
the range of available stable gains is reduced, which makes
the operating gains less robust and reduces the achievable
performance objectives.
Consumption of intermediates in autocatalytic metabolic
pathways results in less resources available to convert to the
product of the pathway, which effectively reduces the net
product of the pathway (i.e., how much product y is produced
per unit y invested in the autocatalytic step). This effective
reduction in net output production makes the pathway harder
to control because it corresponds with the RHP zero getting
smaller, and thus aggravating the tradeoffs on performance
limits. Additionally, these pathways must enforce a positive
return in the energy investment, i.e., for each unit of y
invested at the beginning, it must produce at least that much y
produced by the end of the pathway. Therefore, the loss of the
intermediates to the other pathways must be only a fraction
of the available resources, otherwise excessive consumption
of these intermediates causes the pathway to crash.
On the other hand, the presence of reversible reactions
makes the autocatalytic pathways easier to control, as they
function as “release valves” by making higher stable gains
available, thus providing more robustness and better achiev-
able performance objectives. Figure 8 shows a summary of
the role of concentration of catalyzing enzymes, pathway
size, consumption of intermediate metabolites, and reversible
reactions in determining the stability and performance of the
pathway.
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